Cutaquig(®) Is Well Tolerated in Immunodeficient Patients Who Did Not Tolerate Other Subcutaneous Immunoglobulin Products

por Brownlee, Sydney, Allen, Crystal, Kana’an, Mohammed F., Cameron, D. William, Cowan, Juthaporn
Publicado 2022

Hospital-Based Ocular Trauma: Factors, Treatment, And Impact Outcome

por Ababneh, Laila T, Mohidat, Hasan, Abdelnabi, Heba, Kana’an, Mohammed F, Tashtush, Nour A, El-Mulki, Omar S, Aleshawi, Abdelwahab J
Publicado 2019